Risk Assessment Medical Device Template for the United Arab Emirates

Generate a bespoke document

Trusted by 200k+ teams

4.7 Capterra
4.8 Product Hunt
4.6 Trustpilot

What is a Risk Assessment Medical Device?

The Risk Assessment Template Medical Device is designed to meet the stringent regulatory requirements of the United Arab Emirates' medical device sector. It is essential for manufacturers, importers, and healthcare facilities seeking to ensure compliance with UAE federal regulations while maintaining international best practices in risk management. This template should be used when introducing new medical devices to the UAE market, making significant modifications to existing devices, or conducting periodic risk reviews as required by regulatory authorities. The document incorporates requirements from UAE Federal Law No. 8 of 2019, MOHAP guidelines, and international standards, providing a comprehensive framework for risk identification, analysis, and mitigation. It includes sections for documenting device-specific hazards, risk control measures, benefit-risk analysis, and post-market surveillance planning, making it an essential tool for maintaining regulatory compliance and patient safety in the UAE healthcare system.

Frequently Asked Questions

Is a risk assessment medical device document legally required under UAE Federal Law No. 8 of 2019?

Yes, risk assessment documentation is mandatory under UAE Federal Law No. 8 of 2019 and Cabinet Decision No. 38 of 2021. Medical device manufacturers and importers must provide comprehensive risk assessment documentation following UAE.S ISO 14971:2019 standards as part of the MOHAP registration process. Failure to submit proper risk assessment documentation will result in registration rejection.

Can MOHAP reject my medical device registration if risk assessment documentation is incomplete?

Yes, MOHAP will reject incomplete risk assessment documentation under Cabinet Decision No. 38 of 2021 requirements. Missing risk analysis, inadequate mitigation measures, or non-compliance with UAE.S ISO 14971:2019 standards will result in registration refusal. You'll need to resubmit complete documentation, which can delay market entry by several months and incur additional fees.

How does UAE risk assessment differ from EU MDR or FDA requirements for medical devices?

UAE risk assessment follows UAE.S ISO 14971:2019 standards but requires specific compliance with Federal Law No. 8 of 2019 and Cabinet Decision No. 38 of 2021. Unlike EU MDR, UAE focuses more on post-market surveillance requirements and local authorized representative obligations. The documentation must be in Arabic or officially translated, and risk classification follows UAE-specific categories rather than EU or FDA classifications.

How long does it typically take to prepare compliant risk assessment documentation for UAE medical device registration?

Preparing comprehensive risk assessment documentation typically takes 4-8 weeks for experienced teams, depending on device complexity and risk classification. First-time applicants or complex Class III devices may require 12-16 weeks to ensure full compliance with UAE.S ISO 14971:2019 and MOHAP guidelines. Translation requirements and local regulatory review can add additional 2-4 weeks to the timeline.

Which medical device risk classification system does UAE MOHAP follow under Federal Law No. 8 of 2019?

UAE follows a risk-based classification system under Cabinet Decision No. 38 of 2021, categorizing devices into Classes I, IIa, IIb, and III based on risk levels. The classification considers intended use, duration of contact, invasiveness, and potential harm to patients. Higher-risk devices require more comprehensive risk assessment documentation and stricter post-market surveillance under MOHAP guidelines.

Can I use international ISO 14971 risk assessment templates for UAE medical device registration?

International ISO 14971 templates need significant adaptation for UAE compliance under Federal Law No. 8 of 2019. You must incorporate UAE.S ISO 14971:2019 specific requirements, Cabinet Decision No. 38 of 2021 provisions, and MOHAP guidelines. The documentation must address UAE-specific post-market surveillance, local authorized representative requirements, and Arabic language obligations that aren't covered in generic international templates.

Which common mistakes lead to MOHAP rejection of medical device risk assessment documentation?

Common rejection causes include inadequate risk analysis depth, missing post-market surveillance plans, incorrect device classification under Cabinet Decision No. 38 of 2021, and non-compliance with UAE.S ISO 14971:2019 formatting requirements. Many applicants also fail to properly address local authorized representative obligations and Arabic translation requirements, leading to incomplete submissions that MOHAP cannot process.

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Risk Assessment Medical Device

A Risk Assessment Medical Device template is a comprehensive regulatory document that enables medical device manufacturers and healthcare organizations to systematically evaluate and manage risks associated with medical devices in the United Arab Emirates. This essential compliance tool ensures adherence to UAE federal regulations while protecting patient safety and facilitating market access for medical technologies.

When do you need this document?

You need this risk assessment when introducing any new medical device to the UAE market, as MOHAP requires comprehensive risk documentation for device registration. The assessment is mandatory during the pre-market approval process, particularly for Class IIa, IIb, and III medical devices under UAE classification systems. You must also conduct risk assessments when modifying existing devices, implementing design changes, or identifying new hazards through post-market surveillance. Healthcare facilities require updated risk assessments when adopting new medical technologies or changing clinical protocols. Additionally, you need periodic risk reviews to maintain regulatory compliance and respond to emerging safety concerns or adverse event reports.

Key legal considerations

Your risk assessment must comply with UAE.S ISO 14971:2019 standards, which mandate systematic risk management processes throughout the device lifecycle. The document must include comprehensive hazard identification, risk estimation using quantitative or semi-quantitative methods, and detailed risk control measures with verification and validation evidence. You must demonstrate that residual risks are acceptable when weighed against medical benefits, and document all risk-benefit analyses according to MOHAP guidelines. The assessment requires approval from qualified personnel, including risk assessment leads and quality management representatives, with clear accountability for risk decisions. Your document must establish post-market surveillance procedures to monitor ongoing safety performance and trigger corrective actions when necessary.

Legal requirements in United Arab Emirates

Under Federal Law No. 8 of 2019, all medical devices marketed in the UAE must undergo risk assessment as part of the mandatory registration process with MOHAP or relevant emirate health authorities. Cabinet Decision No. 38 of 2021 specifies detailed requirements for risk documentation, including technical file submissions and quality management system compliance. Your risk assessment must align with UAE.S ISO 13485:2016 standards for medical device quality management systems, ensuring integration with overall quality processes. The document must be prepared by competent persons with appropriate qualifications and maintained throughout the device's commercial life. DOH standards for medical device safety require additional considerations for devices used in Abu Dhabi healthcare facilities. You must ensure your authorized representative in the UAE can access and present risk assessment documentation during regulatory inspections or post-market surveillance activities.

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it